RIPK1 and COVID-19: Finally, in accordance with other papers demonstrating that COVID‐19 patients had more severe ischemic strokes with worse outcomes, we found that S1rp increased oxygen glucose deprivation/reoxygenation‐induced toxicity in an additive manner, via the NRP1/HDAC4/CREB/RIPK1 pathway.